IL80451A0 - Dna sequences,recombinant dna molecules,processes for producing mis-like polypeptides and pharmaceutical containing said peptides - Google Patents

Dna sequences,recombinant dna molecules,processes for producing mis-like polypeptides and pharmaceutical containing said peptides

Info

Publication number
IL80451A0
IL80451A0 IL80451A IL8045186A IL80451A0 IL 80451 A0 IL80451 A0 IL 80451A0 IL 80451 A IL80451 A IL 80451A IL 8045186 A IL8045186 A IL 8045186A IL 80451 A0 IL80451 A0 IL 80451A0
Authority
IL
Israel
Prior art keywords
polypeptides
processes
peptides
dna sequences
sequences
Prior art date
Application number
IL80451A
Other languages
English (en)
Original Assignee
Biogen Nv
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Nv, Gen Hospital Corp filed Critical Biogen Nv
Publication of IL80451A0 publication Critical patent/IL80451A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
IL80451A 1985-10-30 1986-10-30 Dna sequences,recombinant dna molecules,processes for producing mis-like polypeptides and pharmaceutical containing said peptides IL80451A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/792,880 US5047336A (en) 1985-10-30 1985-10-30 DNA sequences, recombinant DNA molecules and processes for producing mullerian inhibiting substance-like polypeptides

Publications (1)

Publication Number Publication Date
IL80451A0 true IL80451A0 (en) 1987-01-30

Family

ID=25158349

Family Applications (1)

Application Number Title Priority Date Filing Date
IL80451A IL80451A0 (en) 1985-10-30 1986-10-30 Dna sequences,recombinant dna molecules,processes for producing mis-like polypeptides and pharmaceutical containing said peptides

Country Status (13)

Country Link
US (1) US5047336A (da)
EP (1) EP0221761B1 (da)
JP (2) JPH0720431B2 (da)
KR (1) KR870004143A (da)
AT (1) ATE119915T1 (da)
AU (1) AU606584B2 (da)
CA (1) CA1307753C (da)
DE (1) DE3650266T2 (da)
DK (1) DK517986A (da)
HU (1) HUT43627A (da)
IL (1) IL80451A0 (da)
PT (1) PT83655B (da)
ZA (1) ZA868251B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047336A (en) * 1985-10-30 1991-09-10 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing mullerian inhibiting substance-like polypeptides
US5427780A (en) * 1985-10-30 1995-06-27 Biogen, Inc. Composition comprising Mullerian inhibiting substance-like polypeptides
JPH03503524A (ja) * 1985-10-30 1991-08-08 バイオジェン インコーポレイテッド ミュレル管阻害物質様ポリペプチドの開裂二量体
US5185441A (en) * 1988-08-26 1993-02-09 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing pi-linked lymphocyte function associated antigen-3
US5661126A (en) * 1989-01-19 1997-08-26 The General Hospital Corporation Use of mullerian inhibiting substance for treating certain tumors and for modulating class I major histocompatibility antigen expression
US5349058A (en) * 1990-02-06 1994-09-20 E. R. Squibb & Sons, Inc. Nucleic acid encoding human mevalonate kinase
US5281520A (en) * 1990-09-12 1994-01-25 Zymogenetics, Inc. Method for producing acyloxyacyl hydrolase
US5310880A (en) * 1991-04-12 1994-05-10 The General Hospital Corporation Purification of Mullerian inhibiting substance
US6764681B2 (en) * 1991-10-07 2004-07-20 Biogen, Inc. Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
WO1993019177A1 (en) * 1992-03-18 1993-09-30 The General Hospital Corporation FOUR NOVEL RECEPTORS OF THE TGF-β RECEPTOR FAMILY
NZ510831A (en) * 1998-08-31 2002-12-20 Biogen Inc Method of modulating memory effector T-cells and compositions
US20020119921A1 (en) * 1999-03-31 2002-08-29 Michael Streit Thrombospondin-2 and uses thereof
EP1218025A4 (en) * 1999-09-14 2005-06-01 Gen Hospital Corp USE OF MULLER CHANNEL INHIBITION SUBSTANCE FOR THE TREATMENT OF PATHOLOGICAL CONDITIONS CHARACTERIZED BY EXCESS ANDROGENES
WO2001055212A2 (en) * 2000-01-27 2001-08-02 The General Hospital Corporation Delivery of therapeutic biological from implantable tissue matrices
CA2451765A1 (en) * 2001-06-05 2002-12-12 Karen K. Oishi Gene expression and production of tgf-b proteins including bioactive mullerian inhibiting substance from plants
EP1419236A4 (en) * 2001-07-24 2005-08-03 Biogen Idec Inc METHODS OF TREATING OR PREVENTING SCLEROSIS BY USE OF CD2-BINDING AGENTS
AU2003262847A1 (en) * 2002-08-23 2004-03-11 The General Hospital Corporation Use of mullerian inhibiting substance and interferon for treating tumors
MXPA06008918A (es) * 2004-02-06 2007-03-07 Astellas Llc Metodos de tratamiento de trastornos de la piel.
US20080020383A1 (en) * 2004-05-04 2008-01-24 Genaissance Pharmaceuticals, Inc. Haplotype Markers And Methods Of Using The Same To Determine Response To Treatment
CA2565259A1 (en) * 2004-05-07 2005-12-08 Astellas Us Llc Soluble lfa-3 polypeptide for treating viral disorders
WO2006118617A2 (en) * 2004-12-23 2006-11-09 Chlorogen, Inc. EXPRESSING TGF-β PROTEINS IN PLANT PLASTIDS
US20060216294A1 (en) * 2005-03-24 2006-09-28 Mclennan Ian S Method of modulation
WO2007049977A2 (en) * 2005-10-26 2007-05-03 Otago Innovation Limited Method of modulation of mullerian inhibitory substance (mis) receptor for the treatment of neurodegenerative diseases.
US20100233689A1 (en) 2007-03-22 2010-09-16 The General Hospital Corporation Pyrazoloanthrone and derivatives thereof for the treatment of cancer expressing 'mullerian inhibiting substance' type ii receptor (misrii) and of excess androgen states
US9289492B2 (en) 2007-07-17 2016-03-22 The General Hospital Corporation Collecting ovarian cancer stem cells from ovarian cancer cells
ITRM20120285A1 (it) 2012-06-18 2013-12-19 Alfonso Baldi Ormone anti-mulleriano.
AU2014248768A1 (en) * 2013-03-12 2015-09-24 Massachusetts Eye And Ear Infirmary Modified mullerian inhibiting substance (MIS) proteins and uses thereof for the treatment of diseases
RU2616273C1 (ru) * 2016-04-21 2017-04-13 Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства Синтетическая ДНК, кодирующая антимюллеров гормон человека, содержащий ее экспрессионный вектор pTVK4pu/MISOPT и штамм клеток яичников китайского хомячка CHO-MIS - продуцент рекомбинантного антимюллерового гормона человека

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404188A (en) * 1981-07-29 1983-09-13 Massachusetts General Hospital Purified Mullerian Inhibiting Substance and method of purification
US4510131A (en) * 1981-07-29 1985-04-09 The General Hospital Corporation Purified Mullerian Inhibiting Substance and method of use
US4442205A (en) * 1981-09-22 1984-04-10 The United States Of America As Represented By The Department Of Health And Human Services Simian virus recombinant that directs the synthesis of hepatitis B surface antigen
US4487833A (en) * 1982-03-01 1984-12-11 The General Hospital Corporation Method of preparing hybridomas and of purifying immunogenic materials
US4740587A (en) * 1985-07-18 1988-04-26 The Salk Institute For Biological Studies Inhibin and method of purifying same
US5047336A (en) * 1985-10-30 1991-09-10 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing mullerian inhibiting substance-like polypeptides

Also Published As

Publication number Publication date
EP0221761B1 (en) 1995-03-15
JPS62190084A (ja) 1987-08-20
ZA868251B (en) 1988-09-28
ATE119915T1 (de) 1995-04-15
DK517986D0 (da) 1986-10-29
CA1307753C (en) 1992-09-22
HUT43627A (en) 1987-11-30
KR870004143A (ko) 1987-05-07
US5047336A (en) 1991-09-10
PT83655B (en) 1988-11-29
DE3650266T2 (de) 1995-08-31
AU6452186A (en) 1987-05-07
JPH0720431B2 (ja) 1995-03-08
EP0221761A3 (en) 1988-10-12
DE3650266D1 (de) 1995-04-20
PT83655A (en) 1986-11-01
AU606584B2 (en) 1991-02-14
DK517986A (da) 1987-05-01
JP2541761B2 (ja) 1996-10-09
JPH06133793A (ja) 1994-05-17
EP0221761A2 (en) 1987-05-13

Similar Documents

Publication Publication Date Title
IL80451A0 (en) Dna sequences,recombinant dna molecules,processes for producing mis-like polypeptides and pharmaceutical containing said peptides
ZA831094B (en) Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides
ZA81103B (en) Dna sequences ,recombinant dna molecules dna molecules and processes for producing human interferon -like polypeptides
CY1346A (en) Dna sequences,recombinant dna molecules and processes for producing human interferon-like polypeptides
HK1013847A1 (en) Gdf-1 and uog-1 proteins
ZA822855B (en) Bacillus cloning vectors,recombinant dna molecules,bacillus hosts transformed with them and methods for expressing foreign dna sequences and producing polypeptides coded thereby
BG100771A (en) Hematopoeic protein and ways and methods for its preparation
ATE49233T1 (de) Vektoren zur transformation von hefe.
ZA86217B (en) Dna sequences,recombinant dna molecules and processes for producing human lipocortin-like polypeptides
ES8802159A1 (es) Un procedimiento de producir un acido desoxirribonucleico (adn)que tiene o contiene una secuencia de base que codificaun polipeptido de factor de necrosis tumoral de humano
TW581808B (en) Compounds for immunotherapy of prostate cancer and methods for their use
ATE252151T1 (de) Apoptosegen von wirbeltieren, zusammensetzungen und verwendungen
AU4778101A (en) Novel polypeptides, and nucleic acids encoding the same
ZA859437B (en) Dna sequence encoding a hirudin-like protein and process for preparing such protein
EP0091527A3 (en) Dna sequences, recombinant dna molecules and processes for producing human serum albumin-like polypeptides
ES8708013A1 (es) Procedimiento para preparar plasmidos de expresion prhw11 y prhw12
IL84700A (en) Hybrid proteins,dnas coding therefor,hybrid vectors containing such dnas and hosts transformed therewith,the preparation of such hybrid proteins and pharmaceutical compositions containing them
ES8704207A1 (es) Procedimiento para preparar una molecula de adn
HUT46359A (en) Dna molecules encoding deacetoxy-cefalosporin-c-synthetase and deacetyl-cefalosporin-c-synthetase and recombinant dna vectors
GR3034725T3 (en) Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy.
EP0170266A3 (en) Process for producing protein, and vector, recombinant dna and transformant used therefor
ES8800353A1 (es) Procedimiento de clonacion de factor humano viii-r.
EP0146903A3 (en) Production of a vector encoding a novel hybrid interferon species
BR0008917A (pt) Compostos
EP0367641A3 (en) Lymphokines, dna sequences encoding these lymphokines and pharmaceutical compositions containing these lymphokines